Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
Zangi NatBiotech2013.pdf (2.085Mb)
Access StatusFull text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.
Lui, Kathy O
von Gise, Alexander
Li, Ronald A
Chien, Kenneth RNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationZangi, Lior, Kathy O Lui, Alexander von Gise, Qing Ma, Wataru Ebina, Leon M Ptaszek, Daniela Später, et al. 2013. “Modified mRNA Directs the Fate of Heart Progenitor Cells and Induces Vascular Regeneration after Myocardial Infarction.” Nature Biotechnology 31, no. 10: 898–907.
AbstractIn a cell-free approach to regenerative therapeutics, transient application of paracrine factors in vivo could be used to alter the behavior and fate of progenitor cells to achieve sustained clinical benefits. Here we show that intramyocardial injection of synthetic modified RNA (modRNA) encoding human vascular endothelial growth factor-A (VEGF-A) results in the expansion and directed differentiation of endogenous heart progenitors in a mouse myocardial infarction model. VEGF-A modRNA markedly improved heart function and enhanced long-term survival of recipients. This improvement was in part due to mobilization of epicardial progenitor cells and redirection of their differentiation toward cardiovascular cell types. Direct in vivo comparison with DNA vectors and temporal control with VEGF inhibitors revealed the greatly increased efficacy of pulse-like delivery of VEGF-A. Our results suggest that modRNA is a versatile approach for expressing paracrine factors as cell fate switches to control progenitor cell fate and thereby enhance long-term organ repair.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:13362673
- FAS Scholarly Articles